Celgene
Why Robinhood?
You can watch Celgene and buy or sell other stocks, ETFs, and their options commission-free!About CELG
Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza.
CELG Key Statistics
Stock Snapshot
The current Celgene(CELG) stock price is $108.24, with a market capitalization of 77.04B. The stock trades at a price-to-earnings (P/E) ratio of 13.32.
On 2026-04-19, Celgene(CELG) stock opened at —, reached a high of —, and a low of —.
Celgene(CELG) shares are trading with a volume of 0, against a daily average of 27.24M.
During the past year, Celgene(CELG) stock moved between $58.59 at its lowest and $110.70 at its peak.
During the past year, Celgene(CELG) stock moved between $58.59 at its lowest and $110.70 at its peak.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.